Insulet Performs Executive Shuffle

Billerica, Mass.-based Insulet Corporation elected John Fallon, M.D., as lead director of Insulet’s board of directors. Fallon has served on the Insulet board since 2012 and replaces Daniel Levangie who is resigning in order to assume the newly-created role of president, Insulet drug delivery.

“Insulet has many exciting opportunities to capitalize on our core technology underpinning our innovative drug delivery devices,” said Levangie. “As I transition to Insulet’s executive leadership team, I am confident that John’s strong leadership, considerable industry and board experience and commitment to the company make him ideally suited for the lead director role. I am confident that the board and management will continue to benefit from his expertise and insights.”

Fallon also serves on the board of directors of AMAG Pharmaceuticals. Since 2004, he has served as the chief physician executive and senior vice president of Blue Cross Blue Shield of Massachusetts. From 2000 to 2004, he held the position of CEO for clinical affairs at the State University of New York Medical Center. In 1995, Fallon became a founding Trustee of Partners Community HealthCare Inc. (PCHI), the Physician Network for Partners HealthCare System founded by The Massachusetts General Hospital and The Brigham and Women’s Hospital, and in 1998 he went on to become Chairman of PCHI. He has served as founder, president and CEO of North Shore Health System, chief medical executive and later CEO of Charter Professional Services Corporation, and first chief medical officer for North Shore Medical Center. Fallon has more than 35 years of experience as a practicing physician, senior executive and participant in numerous medical boards and committees in the health care industry.

Insulet makes insulin pumps for the treatment of diabetes.